(Q35903806)

11 August 2017

Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells (English)

1 reference

11 August 2017

Marcella Sarzotti-Kelsoe

14

object named as

Marcella Sarzotti-Kelsoe

1 reference

11 August 2017

Yunda Huang

6

0 references

David C. Montefiori

13

object named as

David C Montefiori

1 reference

11 August 2017

7

Maggie Wang

1 reference

11 August 2017

Christopher A Todd

1

1 reference

11 August 2017

Kelli M Greene

2

1 reference

11 August 2017

Xuesong Yu

3

1 reference

11 August 2017

Daniel A Ozaki

4

1 reference

11 August 2017

Hongmei Gao

5

1 reference

11 August 2017

Gary Li

8

1 reference

11 August 2017

Ronald Brown

9

1 reference

11 August 2017

Blake Wood

10

1 reference

11 August 2017

M Patricia D'Souza

11

1 reference

11 August 2017

Peter Gilbert

12

1 reference

11 August 2017

language of work or name

English

0 references

publication date

22 September 2011

1 reference

Journal of Immunological Methods

11 August 2017

1 reference

11 August 2017

375

1 reference

11 August 2017

1-2

1 reference

11 August 2017

57-67

1 reference

The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

International network for comparison of HIV neutralization assays: the NeutNet report

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Antibody neutralization and escape by HIV-1

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332116

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21968254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21968254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JIM.2011.09.007

1 reference

11 August 2017

1 reference

11 August 2017

1 reference